Stay updated on pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.

Latest updates to the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page
- CheckyesterdayChange DetectedNo additions or deletions were observed on the Study Details page for NCT03600350. The content appears unchanged.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check30 days agoChange Detected- Added a government funding notice about potential delays and status; - Updated version from v3.1.0 to v3.2.0; - Removed the previous v3.1.0 tag.SummaryDifference3%

- Check37 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check51 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed; core content and data remain unchanged.SummaryDifference0.2%

- Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as a detailed list of publications related to a specific clinical trial. Notably, the drug sargramostim has been both added and removed, indicating a potential revision in its relevance or context within the content.SummaryDifference6%

Stay in the know with updates to pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.